ImmVira Announces Series C Financing with Leading Specialist Investors
- Thursday, December 31, 2020, 7:10
- PR Newswire
- Add a comment
SHENZHEN, China, Dec. 31, 2020 /PRNewswire/ — ImmVira Group Company (“the Company”), a biotechnology platform dedicated to the development of oncolytic virus(“OV”) and vector type approaches to create more effective and safer therapies against cancer, announced today the signing of…
About the Author
admin has written 20014 stories on this site.